SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is experiencing significant upward momentum and record volume as the community anticipates major catalysts, including the 80th trial event and potential buyout interest. The stock's rapid appreciation has sparked intense debate over a potential short squeeze, with investors closely watching borrowing fees and institutional activity while debating the long-term potential of the company's oncology pipeline.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as investors monitor its recent inclusion in the Russell 2000 and 3000 indexes, which has sparked significant debate regarding potential liquidity inflows versus ongoing volatility and dilution concerns. The community is deeply divided, with bulls highlighting the company's expanding defense contracts and drone sector tailwinds, while bears remain focused on persistent downward price trends and recent resale registration filings.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is gaining investor attention as it prepares to initiate a pivotal Phase 3 clinical trial for its lead candidate in non-small cell lung cancer, a major catalyst that follows its established Phase 3 success in prostate cancer. The community is actively discussing the stock's significant long-term upside potential, citing the recent hiring of a new Chief Commercial Officer and expectations that the company is a prime candidate for a multi-billion dollar acquisition by major pharmaceutical players.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending as investors react to a significant earnings beat and a massive $1.2 billion backlog, signaling strong demand despite some investor caution regarding forward guidance and margin pressure. The community is actively debating the stock's potential for a short squeeze against concerns over internal accounting risks and class-action legal headwinds.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk Inc. (TTD) remains a central topic of intense community debate as the stock faces continued downward pressure, fueled by aggressive shorting and ongoing analyst downgrades that investors are labeling as market manipulation. While retail sentiment is sharply dividedwith many frustrated over management's perceived lack of clear communication and underperformanceothers see a generational buying opportunity, pointing to strong fundamentals, the founder's insider accumulation, and recent strategic partnerships as catalysts for a potential long-term reversal.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is rallying as traders capitalize on the company's emerging solid-state transformer technology, which is being positioned as a key infrastructure play for the booming AI data center market. Community sentiment is currently driven by a mix of heavy short-covering, bullish insider buying, and high expectations for the company to secure major partnerships in the power hardware sector.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as investors react to a new manufacturing alliance with Toyota and ongoing progress in FAA certification milestones. The community is sharply divided, with bulls pointing to the company's strong cash position and strategic partnerships, while bears continue to highlight concerns over cash burn and potential share dilution.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors speculate on near-term catalysts, including potential international expansion for its Anktiva therapy and upcoming Q2 sales reporting. The community is actively debating the impact of the stock's recent performance on institutional holdings and short interest, while dismissing noise surrounding index rebalancing in favor of long-term growth driven by global manufacturing and clinical progress.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending as investors monitor the upcoming closing of its acquisition of TopBuild, with the community actively debating the impact of short interest, recent debt financing success, and the potential for a long-term valuation turnaround. Discussion remains heavily focused on the stock's volatility, dilution concerns, and the conviction among long-term holders that the company's ambitious M&A strategy will unlock significant value as the deal finalizes.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore is trending as the community closely monitors operational ramp-up progress and potential federal support via the Defense Production Act, while debating the impact of legal disputes with California regulators on the stock's valuation. Investors are actively discussing the company's ability to successfully refinance its debt and achieve targeted production milestones following the start of crude oil sales to Chevron.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Polaryx Therapeutics (NASDAQ:PLYX) Trading 4.9% Higher - Time to Buy?

Polaryx Therapeutics (NASDAQ:PLYX) Shares Up 4.9% - Here's Why...

Polaryx Therapeutics (NASDAQ:PLYX) Stock Price Down 1.9%  - Time to Sell?

Polaryx Therapeutics (NASDAQ:PLYX) Trading Down 1.9% - Time to Sell...

Battered Polaryx Stock Turns Retail-Trader Heads After 70% Surge: What’s Behind The Sudden Interest?

Equity

Watcher count for PLYX on Stocktwits increased by nearly 50% in a single day.


Maxim Group Begins Coverage on Polaryx Therapeutics (NASDAQ:PLYX)

Maxim Group began coverage on Polaryx Therapeutics in a report on Friday. They set a "buy" rating and a $10.00 price objective on the stock...

Polaryx Therapeutics (NASDAQ:PLYX) Shares Up 15.2% - Here's Why

Polaryx Therapeutics (NASDAQ:PLYX) Shares Up 15.2% - Here's Why...

What's Going On With Polaryx Therapeutics Stock Wednesday?

Polaryx Therapeutics Inc. (NASDAQ: PLYX) stock fell after a surge due to a major clinical development announcement.read more...

Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans

Polaryx Therapeutics (NASDAQ: PLYX) shares rise on selecting research organization for SOTERIA trial to evaluate lead candidate for lysosomal storage disorders.read more...

Polaryx Therapeutics, Inc. engages in the manufacturing of biotechnology products. Its pipeline of products includes PLX-100, PLX-200, and PLX-300. The company was founded by Hahn-Jun Lee on August 22, 2014 and is headquartered in Paramus, NJ.

Polaryx Therapeutics Inc.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

PLYXPolaryx Therapeutics Inc.

Latest PLYX News